Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on May 21, 2025

Cangrade Launches Newly Patented Resume Ranker, Enabling Recruiters to Uncover High-Fit Candidates Quickly and Accurately
WATERTOWN, Mass., May 21, 2025 (GLOBE NEWSWIRE) -- Cangrade today announced the launch of its newly patented Resume Ranker (U.S. Patent No. 12,287,833), an AI feature that enables recruiters to quickly and effectively narrow down high-fit candidates from …

Flywire Surpasses $320 Million in Past-Due Tuition Collected and 161,000+ Student Enrollments Saved at U.S. Higher Education Institutions
Flywire’s Student Financial Software helps U.S. institutions boost enrollment and accelerate cash flow Automated payment innovation fuels accelerated adoption of Flywire's Third-Party Invoicing and 529 Disbursement solutions BOSTON, May 21, 2025 (GLOBE …

ABLi Therapeutics Announces Details of the End of Phase 2 Meeting with FDA for Evaluation of Risvodetinib as a Treatment for Parkinson’s Disease
Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa initiation as an endpoint to measure trial success, which Company believes is a direct measure of …

Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercialization of specialty therapies for specialists and community care providers, that address important …

SparkCharge Raises $30.5 Million in Capital to Accelerate Mobile EV Charging Expansion
SOMERVILLE, Mass., May 21, 2025 (GLOBE NEWSWIRE) -- SparkCharge, the world’s largest off-grid electric vehicle fleet charging network and creator of the first mobile, off-grid EV charger, today announced the close of a $15.5 million Series A-1 funding …

Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a …

Rapport Therapeutics to Host 2025 Investor and Analyst Day
BOSTON and SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or …

Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been dosed in …